Carbon ion radiation for residual thymus tumor after surgery
Part of Injuries & trauma clinical trials.
This trial tests a type of radiation called carbon ion therapy for people with thymus cancer that was not completely removed during surgery. The goal is to see if this treatment can target the remaining tumor cells safely and effectively.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had surgery for a thymus tumor, but some cancer was left behind (visible tumor).
- Your tumor is stage II, III, or IV (Masaoka-Koga staging).
- You are between 18 and 70 years old.
- You are generally able to take care of yourself (ECOG 0-2).
- Your blood, lung, heart, liver, and kidney function are good enough for treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of radiation using carbon ions to treat large tumors in the chest that have come back or not responded to prior treatments. It aims to see if this therapy is safe and effective for people who have few options.
This trial tests carbon ion radiotherapy for adults 75 and older with locally advanced non-small cell lung cancer who cannot have surgery. The goal is to see if this precise type of radiation can treat the cancer effectively with fewer side effects.
This trial tests a shorter course of radiation therapy (hypofractionated) after surgery for people with Stage II or III thymoma or thymic cancer. The goal is to prevent the tumor from coming back.
This trial tests a shorter course of radiation therapy (hypofractionated) given after surgery for thymoma or thymic carcinoma. The goal is to see if this approach is safe and effective for people with stage I to III disease who need radiation after their thymus gland was removed.
This trial tests a precise type of radiation called carbon ion radiotherapy for people with aggressive brain tumors (high-grade gliomas). It aims to see if this treatment is safe and effective for patients who have not had radiation to the head before.
This trial tests a new type of radiation (carbon ion) plus chemotherapy for thymic tumors that cannot be removed with surgery. It aims to see if this combination can effectively treat the cancer while protecting healthy organs.
Hear when a new Thymic Epithelial Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.